Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165684 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
A Phase 4 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 4
- Development phase
- 401
- Enrollment target
NCT01165684 is a Phase 4 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 401 participants.
The verdict
NCT01165684, a Phase 4 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 401 participants
- Enrollment target
Study Summary
This trial is conducted in Europe, and North and South America. The aim of this clinical trial is to investigate if the two treatments are equally effective.
Interventions
- DRUG insulin aspart
- DRUG insulin detemir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01165684
The ClinicalTrials.gov registry entry for NCT01165684 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which insulin aspart is the first listed.
NCT01165684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01165684 about?
NCT01165684 is a clinical study titled "Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen". This trial is conducted in Europe, and North and South America. The aim of this clinical trial is to investigate if the two treatments are equally effective.
What is the current status of trial NCT01165684?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 401 participants. The study started on 2010-10. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01165684?
The interventions under investigation include: insulin aspart (DRUG), insulin detemir (DRUG).
Who is sponsoring clinical trial NCT01165684?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.